Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood–Adulthood Transition

Abstract:Gastrointestinal disorders, although clinically heterogeneous, share pathogenic mechanisms, including genetic susceptibility, impaired gut barrier function, altered microbiota, and environmental triggers (infections, social and behavioral factors, epigenetic control, and diet). Gut microbiota has been studied for inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) in either children or adults, while modifiable gut microbiota features, acting as risk and premorbid factors along the childhood-adulthood transition, have not been thoroughly investigated so far. Indeed, the relationship between variations of the entire host/microbiota/environmental scenario and clinical phenotypes is still not fully understood. In this respect, tracking gut dysbiosis grading may help deciphering host phenotype–genotype associations and microbiota shifts in an integrated top–down omics-based approach within large-scale pediatric and adult case-control cohorts. Large-scale gut microbiota signatures and host inflammation patterns may be integrated with dietary habits, under genetic and epigenetic constraints, providing gut dysbiosis profiles acting as risk predictors of IBD or IBS in preclinical cases. Tracking dysbiosis supports new personalized/stratified IBD and IBS prevention programmes, generating Decision Support System tools. They include (1) high risk or flare-up recurrence -omics-based dysbiosis profiles; (2) microbial and molecular biomarkers of health and disease; (3) -omics-based pipelines for laboratory medicine diagnostics; (4) health apps for self-management of score-based dietary profiles, which can be shared with clinicians for nutritional habit and lifestyle amendment; (5) -omics profiling data warehousing and public repositories for IBD and IBS profile consultation. Dysbiosis-related indexes can represent novel laboratory and clinical medicine tools preventing or postponing the disease, finally interfering with its natural history.

[1]  Frederick C. Neidhardt,et al.  Escherichia coli and Salmonella :cellular and molecular biology , 2016 .

[2]  B. Dallapiccola,et al.  Understanding probiotics’ role in allergic children: the clue of gut microbiota profiling , 2015, Current opinion in allergy and clinical immunology.

[3]  E. Zoetendal,et al.  Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis. , 2015, Gastroenterology.

[4]  M. Carabotti,et al.  The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems , 2015, Annals of gastroenterology.

[5]  P. Bytzer,et al.  The prevalence of intestinal parasites is not greater among individuals with irritable bowel syndrome: a population-based case-control study. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  A. Carroccio,et al.  Role of FODMAPs in Patients With Irritable Bowel Syndrome. , 2015, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[7]  T. Lawley,et al.  Pathogens' exploitation of the intestinal food web. , 2014, Cell host & microbe.

[8]  Dan Knights,et al.  Complex host genetics influence the microbiome in inflammatory bowel disease , 2014, Genome Medicine.

[9]  Ivan Merelli,et al.  Managing, Analysing, and Integrating Big Data in Medical Bioinformatics: Open Problems and Future Perspectives , 2014, BioMed research international.

[10]  K. Lohmann,et al.  Next Generation Sequencing and the Future of Genetic Diagnosis , 2014, Neurotherapeutics.

[11]  D. Dumitrascu,et al.  The relationship between irritable bowel syndrome and psychiatric disorders: from molecular changes to clinical manifestations , 2014, Journal of molecular psychiatry.

[12]  R. Knight,et al.  Finding the missing links among metabolites, microbes, and the host. , 2014, Immunity.

[13]  Weixu Chen,et al.  Implication of miRNAs for inflammatory bowel disease treatment: Systematic review. , 2014, World journal of gastrointestinal pathophysiology.

[14]  A. Kostic,et al.  The microbiome in inflammatory bowel disease: current status and the future ahead. , 2014, Gastroenterology.

[15]  F. Shanahan,et al.  Manipulation of the microbiota for treatment of IBS and IBD-challenges and controversies. , 2014, Gastroenterology.

[16]  B. Dallapiccola,et al.  The human gut microbiota: a dynamic interplay with the host from birth to senescence settled during childhood , 2014, Pediatric Research.

[17]  Gerhard G. Thallinger,et al.  A Physicians' Wish List for the Clinical Application of Intestinal Metagenomics , 2014, PLoS medicine.

[18]  R. Sartor,et al.  The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications , 2014, Journal of Gastroenterology.

[19]  S. McClean,et al.  Reduced E‐cadherin expression is associated with abdominal pain and symptom duration in a study of alternating and diarrhea predominant IBS , 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[20]  Xiuping Liu,et al.  Downregulation of microRNA‐107 in intestinal CD11c+ myeloid cells in response to microbiota and proinflammatory cytokines increases IL‐23p19 expression , 2014, European journal of immunology.

[21]  N. Câmara,et al.  Intestinal barrier: A gentlemen's agreement between microbiota and immunity. , 2014, World journal of gastrointestinal pathophysiology.

[22]  M. Camilleri,et al.  On the fiftieth anniversary Postinfectious irritable bowel syndrome: mechanisms related to pathogens , 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[23]  L. Pieroni,et al.  A metaproteomic pipeline to identify newborn mouse gut phylotypes. , 2014, Journal of proteomics.

[24]  David P. Kreil,et al.  Bacterial protein signals are associated with Crohn’s disease , 2014, Gut.

[25]  A. Vaiopoulou,et al.  Molecular basis of the irritable bowel syndrome. , 2014, World journal of gastroenterology.

[26]  L. Henry,et al.  Systematic review with meta‐analysis: non‐alcoholic steatohepatitis ‐ a case for personalised treatment based on pathogenic targets , 2014, Alimentary pharmacology & therapeutics.

[27]  T. Brusko,et al.  Influence of host immunoregulatory genes, ER stress and gut microbiota on the shared pathogenesis of inflammatory bowel disease and Type 1 diabetes. , 2013, Immunotherapy.

[28]  K. Verbeke,et al.  Metabolomics as a diagnostic tool in gastroenterology. , 2013, World journal of gastrointestinal pharmacology and therapeutics.

[29]  P. Scanlan,et al.  Blastocystis: getting to grips with our guileful guest. , 2013, Trends in parasitology.

[30]  C. Buffie,et al.  Microbiota-mediated colonization resistance against intestinal pathogens , 2013, Nature Reviews Immunology.

[31]  A. Dzutsev,et al.  Intraluminal containment of commensal outgrowth in the gut during infection-induced dysbiosis. , 2013, Cell host & microbe.

[32]  R. Burcelin,et al.  Metagenome and metabolism: the tissue microbiota hypothesis , 2013, Diabetes, obesity & metabolism.

[33]  J. Turner,et al.  Intestinal permeability defects: is it time to treat? , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[34]  P. Bork,et al.  Richness of human gut microbiome correlates with metabolic markers , 2013, Nature.

[35]  Mathieu Almeida,et al.  Dietary intervention impact on gut microbial gene richness , 2013, Nature.

[36]  P. Dorrestein,et al.  Interspecies Interactions Stimulate Diversification of the Streptomyces coelicolor Secreted Metabolome , 2013, mBio.

[37]  R. P. Ross,et al.  Intestinal microbiota, diet and health , 2013, British Journal of Nutrition.

[38]  E. Nimmo,et al.  Beyond Gene Discovery in Inflammatory Bowel Disease: The Emerging Role of Epigenetics , 2013, Gastroenterology.

[39]  C. Huttenhower,et al.  Functional profiling of the gut microbiome in disease-associated inflammation , 2013, Genome Medicine.

[40]  E. Seki,et al.  Toll‐like receptors in alcoholic liver disease, non‐alcoholic steatohepatitis and carcinogenesis , 2013, Journal of gastroenterology and hepatology.

[41]  Gaurav Agrawal,et al.  Fecal Microbiota Transplantation: Indications, Methods, Evidence, and Future Directions , 2013, Current Gastroenterology Reports.

[42]  R. Leong,et al.  Proteomics and metabolomics in inflammatory bowel disease , 2013, Journal of gastroenterology and hepatology.

[43]  Gabriel Núñez,et al.  Control of pathogens and pathobionts by the gut microbiota , 2013, Nature Immunology.

[44]  H. Sokol,et al.  Faecalibacterium prausnitzii and human intestinal health. , 2013, Current opinion in microbiology.

[45]  E. Lyon,et al.  Probiotics, Prebiotics and Immunomodulation of Gut Mucosal Defences: Homeostasis and Immunopathology , 2013, Nutrients.

[46]  A. Petersen,et al.  Active ulcerative colitis associated with low prevalence of Blastocystis and Dientamoeba fragilis infection , 2013, Scandinavian journal of gastroenterology.

[47]  N. Barnich,et al.  Western diet induces dysbiosis with increased E coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation , 2013, Gut.

[48]  J. Bertrand-Michel,et al.  Lipidomic and Spatio-Temporal Imaging of Fat by Mass Spectrometry in Mice Duodenum during Lipid Digestion , 2013, PloS one.

[49]  G. Gloor,et al.  Microbial ecosystems therapeutics: a new paradigm in medicine? , 2013, Beneficial microbes.

[50]  C. R. Stensvold,et al.  Waiting for the human intestinal Eukaryotome , 2013, The ISME Journal.

[51]  A. Knoll,et al.  Animals in a bacterial world, a new imperative for the life sciences , 2013, Proceedings of the National Academy of Sciences.

[52]  Jie-shou Li,et al.  Nonthyroidal Illness Syndrome: Is It Far Away From Crohn’s Disease? , 2013, Journal of clinical gastroenterology.

[53]  Takuya Suzuki Regulation of intestinal epithelial permeability by tight junctions , 2013, Cellular and Molecular Life Sciences.

[54]  Brian C. Thomas,et al.  Time series community genomics analysis reveals rapid shifts in bacterial species, strains, and phage during infant gut colonization , 2013, Genome research.

[55]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[56]  J. Nicholson,et al.  Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk. , 2012, Cell metabolism.

[57]  J. Popp,et al.  Sample size planning for classification models. , 2012, Analytica chimica acta.

[58]  D. Elliott,et al.  Where are we on worms? , 2012, Current opinion in gastroenterology.

[59]  David C. Wilson,et al.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.

[60]  Belgin Dogan,et al.  Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota , 2012, Science.

[61]  Francisco Guarner,et al.  The gut microbiota in IBD , 2012, Nature Reviews Gastroenterology &Hepatology.

[62]  N. Socci,et al.  Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[63]  Enrico Capobianco,et al.  Ten Challenges for Systems Medicine , 2012, Front. Gene..

[64]  D. Raoult,et al.  Human Gut Microbiota: Repertoire and Variations , 2012, Front. Cell. Inf. Microbio..

[65]  R. Knight,et al.  Diversity, stability and resilience of the human gut microbiota , 2012, Nature.

[66]  T. Dinan,et al.  Mind-altering Microorganisms: the Impact of the Gut Microbiota on Brain and Behaviour , 2022 .

[67]  Nuno Bandeira,et al.  Interkingdom metabolic transformations captured by microbial imaging mass spectrometry , 2012, Proceedings of the National Academy of Sciences.

[68]  W. D. de Vos,et al.  Early-life gut microbiota under physiological and pathological conditions: the central role of combined meta-omics-based approaches. , 2012, Journal of proteomics.

[69]  Ruedi Aebersold,et al.  Reproducible Quantification of Cancer-Associated Proteins in Body Fluids Using Targeted Proteomics , 2012, Science Translational Medicine.

[70]  J. Söderholm,et al.  Barrier dysfunction and bacterial uptake in the follicle‐associated epithelium of ileal Crohn's disease , 2012, Annals of the New York Academy of Sciences.

[71]  E. Zoetendal,et al.  Intestinal microbiota in functional bowel disorders: a Rome foundation report , 2012, Gut.

[72]  M. Balter Taking Stock of the Human Microbiome and Disease , 2012, Science.

[73]  F. Azpiroz,et al.  Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier , 2012, Gut.

[74]  Katherine H. Huang,et al.  Structure, Function and Diversity of the Healthy Human Microbiome , 2012, Nature.

[75]  R. Alfenas,et al.  Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia , 2012, British Journal of Nutrition.

[76]  J. Clemente,et al.  Human gut microbiome viewed across age and geography , 2012, Nature.

[77]  R. Vance,et al.  Lethal inflammasome activation by a multi-drug resistant pathobiont upon antibiotic disruption of the microbiota , 2012, Nature Medicine.

[78]  David R Goodlett,et al.  Multiplex targeted proteomic assay for biomarker detection in plasma: a pancreatic cancer biomarker case study. , 2012, Journal of proteome research.

[79]  Y. Ni,et al.  Host-microbial interactions and regulation of intestinal epithelial barrier function: From physiology to pathology. , 2012, World journal of gastrointestinal pathophysiology.

[80]  Qing Zeng-Treitler,et al.  Predicting sample size required for classification performance , 2012, BMC Medical Informatics and Decision Making.

[81]  G. Rook,et al.  Hygiene Hypothesis and Autoimmune Diseases , 2012, Clinical Reviews in Allergy & Immunology.

[82]  H. Kiyono,et al.  Epithelial barrier: an interface for the cross‐communication between gut flora and immune system , 2012, Immunological reviews.

[83]  J. Pekow,et al.  MicroRNAs in inflammatory bowel disease , 2012, Inflammatory bowel diseases.

[84]  M. Schmidt,et al.  Differential Targeting of the E-Cadherin/β-Catenin Complex by Gram-Positive Probiotic Lactobacilli Improves Epithelial Barrier Function , 2011, Applied and Environmental Microbiology.

[85]  Michael A Fischbach,et al.  Eating for two: how metabolism establishes interspecies interactions in the gut. , 2011, Cell host & microbe.

[86]  John F. Cryan,et al.  Brain–Gut–Microbe Communication in Health and Disease , 2011, Front. Physio..

[87]  F. Bushman,et al.  Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes , 2011, Science.

[88]  J. Walter,et al.  The human gut microbiome: ecology and recent evolutionary changes. , 2011, Annual review of microbiology.

[89]  Ateequr Rehman,et al.  Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. , 2011, Gastroenterology.

[90]  J. Gordon,et al.  Human nutrition, the gut microbiome and the immune system , 2011, Nature.

[91]  R. Knight,et al.  Microbial Eukaryotes in the Human Microbiome: Ecology, Evolution, and Future Directions , 2011, Front. Microbio..

[92]  P. Bork,et al.  Enterotypes of the human gut microbiome , 2011, Nature.

[93]  G. Dalmasso,et al.  Microbiota Modulate Host Gene Expression via MicroRNAs , 2011, PloS one.

[94]  M. Levings,et al.  Environmental influences on T regulatory cells in inflammatory bowel disease. , 2011, Seminars in immunology.

[95]  A. Darzi,et al.  Gut microbiome-host interactions in health and disease , 2011, Genome Medicine.

[96]  J. Parkhill,et al.  Dominant and diet-responsive groups of bacteria within the human colonic microbiota , 2011, The ISME Journal.

[97]  K. Honda,et al.  Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species , 2011, Science.

[98]  Julian Parkhill,et al.  High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease , 2011, BMC Microbiology.

[99]  Tariq Ahmad,et al.  Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci , 2010, Nature Genetics.

[100]  L. Putignani,et al.  Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. , 2010, Endocrine reviews.

[101]  J. Doré,et al.  Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray , 2010, Inflammatory bowel diseases.

[102]  A. Dignass,et al.  Diagnosis and management of iron deficiency anemia in patients with IBD , 2010, Nature Reviews Gastroenterology &Hepatology.

[103]  J. Doré,et al.  Functional Metagenomics: A High Throughput Screening Method to Decipher Microbiota-Driven NF-κB Modulation in the Human Gut , 2010, PloS one.

[104]  M. Abdollahi,et al.  A review of the efficacy of traditional Iranian medicine for inflammatory bowel disease. , 2010, World journal of gastroenterology.

[105]  Yu Guo,et al.  Sample size and statistical power considerations in high-dimensionality data settings: a comparative study of classification algorithms , 2010, BMC Bioinformatics.

[106]  J. Roth,et al.  Gut inflammation provides a respiratory electron acceptor for Salmonella , 2010, Nature.

[107]  S. Massart,et al.  Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa , 2010, Proceedings of the National Academy of Sciences.

[108]  A. Ivanov,et al.  Cytoskeletal regulation of epithelial barrier function during inflammation. , 2010, The American journal of pathology.

[109]  J. Neu,et al.  The infant intestinal microbiome: friend or foe? , 2010, Early human development.

[110]  M. Heikenwalder,et al.  Reversible Microbial Colonization of Germ-Free Mice Reveals the Dynamics of IgA Immune Responses , 2010, Science.

[111]  A. Weiss,et al.  EspM inhibits pedestal formation by enterohaemorrhagic Escherichia coli and enteropathogenic E. coli and disrupts the architecture of a polarized epithelial monolayer , 2010, Cellular microbiology.

[112]  P. Bork,et al.  A human gut microbial gene catalogue established by metagenomic sequencing , 2010, Nature.

[113]  R. Knight,et al.  Bacterial Community Variation in Human Body Habitats Across Space and Time , 2009, Science.

[114]  S. Fukudo,et al.  Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[115]  Jerrold R. Turner,et al.  Intestinal mucosal barrier function in health and disease , 2009, Nature Reviews Immunology.

[116]  Dan R. Littman,et al.  Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria , 2009, Cell.

[117]  R. Xavier,et al.  Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43 , 2009, Nature.

[118]  Pieter C. Dorrestein,et al.  Translating metabolic exchange with imaging mass spectrometry , 2009, Nature chemical biology.

[119]  L. Mølbak,et al.  Better living through microbial action: the benefits of the mammalian gastrointestinal microbiota on the host. , 2009, Environmental microbiology.

[120]  P. Whorwell,et al.  Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial , 2009, BMJ : British Medical Journal.

[121]  Michael D. George,et al.  Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. , 2009, Cell host & microbe.

[122]  S. Mazmanian,et al.  The gut microbiota shapes intestinal immune responses during health and disease , 2009, Nature Reviews Immunology.

[123]  P. Rutgeerts,et al.  Pouchitis, Similar to Active Ulcerative Colitis, Is Associated with Impaired Butyrate Oxidation by Intestinal Mucosa , 2009, Inflammatory bowel diseases.

[124]  I. Adlerberth,et al.  Establishment of the gut microbiota in Western infants , 2009, Acta paediatrica.

[125]  Gérard Eberl,et al.  Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis , 2008, Nature.

[126]  M. Spehlmann,et al.  Epidemiology of inflammatory bowel disease in a German twin cohort: Results of a nationwide study , 2008, Inflammatory bowel diseases.

[127]  Asher Mullard Microbiology: The inside story , 2008, Nature.

[128]  S. Ghosh,et al.  Shared Principles in NF-κB Signaling , 2008, Cell.

[129]  P. Ducrotte Syndrome de l'intestin irritable : options thérapeutiques actuelles , 2007 .

[130]  D. Jonkers,et al.  Review article: the role of butyrate on colonic function , 2007, Alimentary pharmacology & therapeutics.

[131]  L. Šver,et al.  Immune development in jejunal mucosa after colonization with selected commensal gut bacteria: a study in germ-free pigs. , 2007, Veterinary immunology and immunopathology.

[132]  R. Coda,et al.  Synthesis of γ-Aminobutyric Acid by Lactic Acid Bacteria Isolated from a Variety of Italian Cheeses , 2007, Applied and Environmental Microbiology.

[133]  C. Knauf,et al.  Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia , 2007, Diabetologia.

[134]  F. Barreau,et al.  New Insights in the Etiology and Pathophysiology of Irritable Bowel Syndrome: Contribution of Neonatal Stress Models , 2007, Pediatric Research.

[135]  N. Pace,et al.  Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases , 2007, Proceedings of the National Academy of Sciences.

[136]  B. Finlay,et al.  Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. , 2007, Cell host & microbe.

[137]  J. Corander,et al.  The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. , 2007, Gastroenterology.

[138]  W. Sandborn,et al.  Inflammatory bowel disease: clinical aspects and established and evolving therapies , 2007, The Lancet.

[139]  A. Gruber,et al.  Epithelial-cell-intrinsic IKK-β expression regulates intestinal immune homeostasis , 2007, Nature.

[140]  M. Neurath,et al.  Epithelial NEMO links innate immunity to chronic intestinal inflammation , 2007, Nature.

[141]  E. Quigley Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management , 2007, Journal of digestive diseases.

[142]  N. Barnich,et al.  Adherent-invasive Escherichia coli and Crohn's disease , 2007, Current opinion in gastroenterology.

[143]  E. Björnsson,et al.  Small intestinal bacterial overgrowth in patients with irritable bowel syndrome , 2006, Gut.

[144]  R. Balshaw,et al.  Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study. , 2006, Clinical therapeutics.

[145]  A. Nusrat,et al.  Inflammatory Bowel Disease and the Apical Junctional Complex , 2006, Annals of the New York Academy of Sciences.

[146]  R. D. de Souza,et al.  Colonic Health: Fermentation and Short Chain Fatty Acids , 2006, Journal of clinical gastroenterology.

[147]  D. Drossman,et al.  A Survey on Patient Educational Needs in Irritable Bowel Syndrome and Attitudes Toward Participation in Clinical Research , 2006, Journal of clinical gastroenterology.

[148]  C. Manichanh,et al.  Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach , 2005, Gut.

[149]  R. Malekzadeh,et al.  The effect of fluoxetine in patients with pain and constipation‐predominant irritable bowel syndrome: a double‐blind randomized‐controlled study , 2005, Alimentary pharmacology & therapeutics.

[150]  C. Bernstein,et al.  The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. , 2005, Gastroenterology.

[151]  J. Eiserich,et al.  Differential regulation of dual NADPH oxidases/peroxidases, Duox1 and Duox2, by Th1 and Th2 cytokines in respiratory tract epithelium , 2005, FEBS letters.

[152]  E. Purdom,et al.  Diversity of the Human Intestinal Microbial Flora , 2005, Science.

[153]  J. J. Windsor,et al.  Irritable bowel syndrome: the need to exclude Dientamoeba fragilis. , 2005, The American journal of tropical medicine and hygiene.

[154]  M. Blaut,et al.  Modulation of gut mucosal biofilms , 2005, British Journal of Nutrition.

[155]  F. Bäckhed,et al.  Host-Bacterial Mutualism in the Human Intestine , 2005, Science.

[156]  T. Ohkusa,et al.  Antibacterial and antimycobacterial treatment for inflammatory bowel disease , 2005, Journal of gastroenterology and hepatology.

[157]  Ting Wang,et al.  The gut microbiota as an environmental factor that regulates fat storage. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[158]  Ruslan Medzhitov,et al.  Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.

[159]  Yu-jing Fan,et al.  Intestinal microecology and quality of life in irritable bowel syndrome patients. , 2004, World journal of gastroenterology.

[160]  B. Cukrowska,et al.  Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. , 2004, Immunology letters.

[161]  R Balfour Sartor,et al.  Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. , 2004, Gastroenterology.

[162]  G. Matarese,et al.  The weight of leptin in immunity , 2004, Nature Reviews Immunology.

[163]  M. Beg,et al.  Irritable bowel syndrome: in search of an etiology: role of Blastocystis hominis. , 2004, The American journal of tropical medicine and hygiene.

[164]  N. Talley Scope of the problem of functional digestive disorders. , 2003, The European journal of surgery. Supplement. : = Acta chirurgica. Supplement.

[165]  A. Keshavarzian,et al.  Intestinal barrier: An interface between health and disease , 2003, Journal of gastroenterology and hepatology.

[166]  S. Savkovic,et al.  Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation , 2003, Gut.

[167]  Jeffrey I. Gordon,et al.  Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[168]  H. Lührs,et al.  Butyrate Inhibits NF-κB Activation in Lamina Propria Macrophages of Patients with Ulcerative Colitis , 2002, Scandinavian journal of gastroenterology.

[169]  G. Scalise,et al.  Irritable Bowel Syndrome in Patients with Blastocystis hominis Infection , 1999, European Journal of Clinical Microbiology and Infectious Diseases.

[170]  Stephen R. Bloom,et al.  Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression , 1998, Nature.

[171]  Chyung-Ru Wang,et al.  Helper T cell differentiation is controlled by the cell cycle. , 1998, Immunity.

[172]  M. Roberfroid,et al.  Functional food science and gastrointestinal physiology and function , 1998, British Journal of Nutrition.

[173]  J. Hampe,et al.  Activation of nuclear factor κB in inflammatory bowel disease , 1998, Gut.

[174]  C. Fiorentini,et al.  Escherichia coli Cytotoxic Necrotizing Factor 1 (CNF1), a Toxin That Activates the Rho GTPase* , 1997, The Journal of Biological Chemistry.

[175]  J. R. Smith,et al.  Role of intestinal epithelial cells in the host secretory response to infection by invasive bacteria. Bacterial entry induces epithelial prostaglandin h synthase-2 expression and prostaglandin E2 and F2alpha production. , 1997, The Journal of clinical investigation.

[176]  J. Belaiche,et al.  Clinical characteristics of Crohn's disease in 72 families. , 1996, Gastroenterology.

[177]  M. O’connor,et al.  Induction and activity of nitric oxide synthase in cultured human intestinal epithelial monolayers. , 1996, The American journal of physiology.

[178]  J. Spencer,et al.  E-cadherin expression in intestinal epithelium. , 1995, Journal of clinical pathology.

[179]  P. Hellström,et al.  Greatly increased luminal nitric oxide in ulcerative colitis , 1994, The Lancet.

[180]  S. Moncada,et al.  Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.

[181]  M. Tvede,et al.  Rectal bacteriotherapy for recurrent Clostridium difficile-associated diarrhoea: results from a case series of 55 patients in Denmark 2000-2012. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[182]  L. Öhman,et al.  Crosstalk at the mucosal border: importance of the gut microenvironment in IBS , 2015, Nature Reviews Gastroenterology &Hepatology.

[183]  M. Geuking,et al.  Pathological bacterial translocation in liver cirrhosis. , 2014, Journal of hepatology.

[184]  Peter Holzer,et al.  Neuropeptides and the microbiota-gut-brain axis. , 2014, Advances in experimental medicine and biology.

[185]  P. Gibson,et al.  A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. , 2014, Gastroenterology.

[186]  Kp Suresh,et al.  Sample size estimation and power analysis for clinical research studies , 2012, Journal of human reproductive sciences.

[187]  E. Szigethy,et al.  Inflammatory bowel disease. , 2011, Pediatric clinics of North America.

[188]  Evie McCrum-Gardner,et al.  Sample size and power calculations made simple , 2010 .

[189]  D. Doman,et al.  Probiotic therapy for irritable bowel syndrome. , 2010, Gastroenterology & hepatology.

[190]  E. Stein,et al.  GERD: GERD and insomnia—first degree relatives or distant cousins? , 2010, Nature Reviews Gastroenterology &Hepatology.

[191]  B. Staels,et al.  Role of bile acids and bile acid receptors in metabolic regulation. , 2009, Physiological reviews.

[192]  Luying Peng,et al.  Effects of Butyrate on Intestinal Barrier Function in a Caco-2 Cell Monolayer Model of Intestinal Barrier , 2007, Pediatric Research.

[193]  D. Stark,et al.  Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis. , 2007, International journal for parasitology.

[194]  P. Ducrotte [Irritable bowel syndrome: current treatment options]. , 2007, Presse medicale.

[195]  Stephen P Myers,et al.  The causes of intestinal dysbiosis: a review. , 2004, Alternative medicine review : a journal of clinical therapeutic.

[196]  Sayan Mukherjee,et al.  Estimating Dataset Size Requirements for Classifying DNA Microarray Data , 2003, J. Comput. Biol..

[197]  Alan D. Lopez,et al.  The Global Burden of Disease Study , 2003 .

[198]  K. E. Shroff,et al.  Development and Maintenance of the Gut-Associated Lymphoid Tissue (Galt): the Roles of Enteric Bacteria and Viruses , 1998, Developmental immunology.

[199]  L. Collins,et al.  Seven ways to increase power without increasing N. , 1994, NIDA research monograph.